{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:50:12Z","timestamp":1791111012700,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.maturitas.2008.10.017","type":"journal-article","created":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T09:40:10Z","timestamp":1230889210000},"page":"338-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Progestogen use in women approaching the menopause and breast cancer risk"],"prefix":"10.1016","volume":"62","author":[{"given":"Carlo","family":"Campagnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ambroggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Lotano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2008.10.017_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.maturitas.2006.06.002","article-title":"Ovarian steroids and the human breast: regulation of stem cells and cell proliferation","volume":"54","author":"Clarke","year":"2006","journal-title":"Maturitas"},{"issue":"S1","key":"10.1016\/j.maturitas.2008.10.017_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestins: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.10.017_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.23081","article-title":"The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner","volume":"122","author":"Leo","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsbmb.2007.12.002","article-title":"Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data","volume":"109","author":"Seeger","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1677\/erc.1.01010","article-title":"Progesterone metabolites in breast cancer","volume":"13","author":"Wiebe","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"S1","key":"10.1016\/j.maturitas.2008.10.017_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/09513590701585003","article-title":"Progestins and breast cancer","volume":"23","author":"Pasqualini","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-006-9276-y","article-title":"Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys","volume":"101","author":"Wood","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2008.10.017_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2005.02.014","article-title":"Progestins and progesterone in hormone replacement therapy and the risk of breast cancer","volume":"96","author":"Campagnoli","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/djj376","article-title":"Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women","volume":"98","author":"Eliassen","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.10.017_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijc.20403","article-title":"Endogenous sex hormones and subsequent breast cancer in premenopausal women","volume":"112","author":"Micheli","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.10.017_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2008.10.017_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2007.13.4338","article-title":"Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer","volume":"26","author":"Fournier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with postmenopausal hormone treatment","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.maturitas.2008.10.017_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(06)70911-1","article-title":"Hormonal therapy for menopause and breast cancer risk by histological type: a cohort study and meta-analysis","volume":"7","author":"Reeves","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment","volume":"14","author":"Biglia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1055-9965.EPI-07-0558","article-title":"Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas","volume":"17","author":"Li","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2008.10.017_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1749-6632.2000.tb06250.x","article-title":"The perimenopausal transition","volume":"900","author":"Speroff","year":"2000","journal-title":"Ann NY Acad Sci"},{"issue":"S5","key":"10.1016\/j.maturitas.2008.10.017_bib19","first-page":"S253","article-title":"The menopausal transition","volume":"86","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.10.017_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.grf.0000159537.89102.97","article-title":"Endocrine mechanisms and management for abnormal bleeding due to perimenopausal changes","volume":"48","author":"Jain","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/175404507780456782","article-title":"Medical management of perimenopausal menorrhagia: an evidence-based approach","volume":"13","author":"Duckitt","year":"2007","journal-title":"Menopause Int"},{"key":"10.1016\/j.maturitas.2008.10.017_bib22","article-title":"The Cochrane Database of Systemic Reviews- Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation","volume":"2","author":"Hickey","year":"2008","journal-title":"Cochrane Libr."},{"issue":"S1","key":"10.1016\/j.maturitas.2008.10.017_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09513590701584923","article-title":"Long-term use of progestogens\u2014effect on endometriosis, adenomyosis and myomas","volume":"23","author":"Schweppe","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"S6","key":"10.1016\/j.maturitas.2008.10.017_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2007.01.010","article-title":"The levonorgestrel intrauterine system for use in peri- and postmenopausal women","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.10.017_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/oxfordjournals.epirev.a017960","article-title":"Epidemiology of benign breast disease, with special attention to histologic types","volume":"19","author":"Goehring","year":"1997","journal-title":"Epidemiol Rev"},{"issue":"S6","key":"10.1016\/j.maturitas.2008.10.017_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/gye.15.s6.37.43","article-title":"Cyclic progestin therapy for the management of mastopathy and mastodynia","volume":"15","author":"Winkler","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10911-006-9006-4","article-title":"Benign breast diseases","volume":"10","author":"Courtillot","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.maturitas.2008.10.017_bib28","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.socscimed.2004.10.021","article-title":"French hormones: progestins and therapeutic variation in France","volume":"60","author":"Lowy","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.maturitas.2008.10.017_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0368-2315(05)82741-3","article-title":"Propause survey: profile of patients treated with progestins in perimenopause","volume":"34","author":"Lop\u00e8s","year":"2005","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.maturitas.2008.10.017_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.maturitas.2007.08.008","article-title":"Association between premenopausal progestogen use and postmenopausal hormone therapy in the GAZEL cohort","volume":"58","author":"Ringa","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.10.017_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1994.291","article-title":"Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease","volume":"70","author":"Plu-Bureau","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6603618","article-title":"Oral progestagens before menopause and breast cancer risk","volume":"96","author":"Fabre","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1701-2163(16)32195-8","article-title":"Progesterone-only and non-hormonal contraception in the breast cancer survivor: joint review and committee opinion of the Society of Obstetricians and Gynaecologist of Canada and the Society of Gynecologic Oncologists of Canada","volume":"28","author":"McNaught","year":"2006","journal-title":"J Obstet Gynaecol Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2004.06.007","article-title":"Exogenous progestagens and the human breast","volume":"49","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.10.017_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1525-1500.1999.99032.x","article-title":"Percutaneous progesterone uses and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease","volume":"23","author":"Plu-Bureau","year":"1999","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.maturitas.2008.10.017_bib36","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1158\/1055-9965.EPI-08-0056","article-title":"Progestagens use before menopause and breast cancer risk according to histology and hormone-receptors","volume":"17","author":"Fabre","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.maturitas.2008.10.017_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwn044","article-title":"Estrogen plus progestin therapy and breast cancer in recently postmenopausal women","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/aje\/kwn090","article-title":"Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2008.10.017_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.23655","article-title":"Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy","volume":"123","author":"Flesch-Janys","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2008.10.017_bib41","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"S1","key":"10.1016\/j.maturitas.2008.10.017_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/09513590701585037","article-title":"Differential effects of various progestogens on metabolic risk factors for breast cancer","volume":"23","author":"Campagnoli","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.10.017_bib43","series-title":"Breast cancer: prognosis, treatment and prevention","first-page":"323","article-title":"Insulin-like Growth Factor-I and breast cancer: epidemiological and clinical data","author":"Campagnoli","year":"2008"},{"key":"10.1016\/j.maturitas.2008.10.017_bib44","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1096\/fj.06-7518com","article-title":"Disruption of androgen receptor signaling by sinthetic progestins may increase risk of developing breast cancer","volume":"21","author":"Birrell","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.maturitas.2008.10.017_bib45","series-title":"Breast cancer: prognosis, treatment and prevention","first-page":"113","article-title":"Progesterone receptors isoforms and human breast cancer","author":"Gompel","year":"2008"},{"key":"10.1016\/j.maturitas.2008.10.017_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2008.10.017_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1020072325818","article-title":"Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception","volume":"3","author":"Stanczyk","year":"2002","journal-title":"Rev Endocr Metab Disorders"},{"key":"10.1016\/j.maturitas.2008.10.017_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/ejso.2002.1423","article-title":"Is invasive lobular carcinoma different from invasive ductal carcinoma?","volume":"29","author":"Mersin","year":"2003","journal-title":"EJSO"},{"key":"10.1016\/j.maturitas.2008.10.017_bib49","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.10.017_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/ENDO:26:3:297","article-title":"Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation","volume":"26","author":"Prior","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.maturitas.2008.10.017_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5122(03)00250-0","article-title":"Menometrorrhagia in the perimenopause is associated with increased serum estradiol","volume":"47","author":"Moen","year":"2004","journal-title":"Maturitas"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208002740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208002740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:46:25Z","timestamp":1759913185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512208002740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0378512208002740"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.10.017","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestogen use in women approaching the menopause and breast cancer risk","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}